Literature DB >> 26235853

Patient satisfaction and function after bilateral ankle arthrodeses.

Philip Vaughan1, David Gordon2, Andy Goldberg2, Nick Cullen2, Dishan Singh2.   

Abstract

BACKGROUND: The optimum way to manage patients with bilateral ankle arthritis (AA) is unclear.
METHODS: This review was performed to report the midterm satisfaction and functional outcome of a series of patients who have undergone bilateral staged ankle arthrodesis.
RESULTS: Eight patients, median age 68.5 yrs (range 59-80) were followed-up for a median of 58.5 months (range 24-100). All fusions united in a median time of 12.8 weeks (range 10-19) Their median AOFAS hindfoot score was 79.5 (range 71-90). Six patients (75%) were very satisfied, one was satisfied, and the other neither satisfied nor dissatisfied. Two patients developed symptomatic subtalar arthritis requiring subtalar fusion.
CONCLUSIONS: This is the first study to report the outcome of bilateral AA independent to that of unilateral AA. Bilateral AA appears to give patients a good functional result with high patient reported satisfaction into the medium term.
Copyright © 2014 European Foot and Ankle Society. Published by Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Arthritis; Bone; Internal fixation; Outcome; Talus; Tibia

Mesh:

Year:  2014        PMID: 26235853     DOI: 10.1016/j.fas.2014.11.001

Source DB:  PubMed          Journal:  Foot Ankle Surg        ISSN: 1268-7731            Impact factor:   2.705


  2 in total

1.  Results of Arthroscopic Ankle Arthrodesis with Fixation Using Two Parallel Headless Compression Screws in a Heterogenic Group of Patients.

Authors:  Lukas Kolodziej; Boguslaw Sadlik; Sebastian Sokolowski; Andrzej Bohatyrewicz
Journal:  Open Orthop J       Date:  2017-02-24

2.  End-stage Ankle Arthritis Treated by Ankle Arthrodesis with Screw Fixation Through the Transfibular Approach: A Retrospective Analysis.

Authors:  Haiqiang Suo; Li Fu; Hanguang Liang; Zhiwei Wang; Jie Men; Wei Feng
Journal:  Orthop Surg       Date:  2020-06-18       Impact factor: 2.071

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.